To assess the ability of GSH and GSS to discriminate between amyloid PET-positive and -negative individuals, receiver operating characteristic (ROC) curve analysis was performed using models based on biomarker concentrations alone, and in combination with age, sex, and APOE 4 carrier status
For clinical procedures high-end and sophisticated technology may come at a premium price compared to outdated and cheaper technologies
FOXO4-DRI is not an approved drug for diagnosing, treating, curing, or preventing disease in humans
Understanding the difference is important, especially for patients already on hormone-related treatments
This regulatory framework isn't weaker, just different, he argues